Status:
COMPLETED
Video Capsule Endoscopy to Investigate the Safety and Tolerability of Lumiracoxib in the Small Bowel
Lead Sponsor:
Novartis
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study is designed to investigate the potential differences in GI safety and tolerability in the small bowel between lumiracoxib, conventional non-selective NSAID (naproxen) with a proton pump inh...
Eligibility Criteria
Inclusion
- Healthy male or female subjects
Exclusion
- Evidence of cardiovascular, hepatic, gastrointestinal or renal disorders
- Hereditary problems of galactose intolerance, a severe lactase deficiency or glucose-galactose malabsorption syndrome
- Smokers
- Other protocol-defined inclusion/exclusion criteria may apply
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00350155
Start Date
May 1 2006
Last Update
December 13 2007
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Wiesbaden, Germany
2
Nottingham, United Kingdom